Comparing a new blood thinner to the standard one
Treatments studied
This study compares a new version of the blood-thinning drug enoxaparin (called a biosimilar) to the standard brand, Clexane. If you are a healthy adult, you might be eligible to participate, which helps ensure the new drug works the same way.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 55 years old.
- Your weight is at least 45 kg and your body mass index (BMI) is between 18.5 and 30.
- Your blood pressure, pulse, and body temperature are in the normal range.
- You are generally healthy, with no major medical conditions, and you do not have bleeding disorders or allergies to this drug.
- You can stop taking all medications (including over-the-counter and herbal) for two weeks before the study, and you can fast for 10 hours.
- You have not participated in a drug trial or donated blood in the past 2 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the blood thinner enoxaparin (Lovenox) is absorbed in people with severe obesity when injected into two different body areas. It aims to see if the standard preventive dose works well, potentially improving clot prevention for people your size.
This study compares two doses of a blood thinner (enoxaparin) to see which better prevents blood clots in patients with severe injuries who are in the intensive care unit. It helps doctors choose the best dose to keep you safe and healthy.
This study tests a new erythropoietin (a medicine that helps your body make red blood cells) and compares it to an approved version called Eprex. It is for healthy adults to see how the two medicines work in the body and if they are safe.
This study looks at how a blood thinner called edoxaban is processed in the body of people with nephrotic syndrome compared to healthy volunteers. It may help doctors understand the right dose for people with kidney issues.
This trial compares three different blood thinners (heparin, argatroban, and enoxaparin) used during ECMO support. It aims to find the safest and most effective way to prevent blood clots while on ECMO.
This trial tests a new medicine (NANOKINE) that helps your body make red blood cells, compared to a well-known drug (Eprex). It is for healthy men to see how safe it is and how it works in the body. If you qualify, you might help develop a better option for treating anemia.
Hear when a new Healthy Participants Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.